These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 39179332)

  • 1. β-Adrenoceptor blockade can augment the torsadogenic action of risperidone.
    Goto A; Kambayashi R; Izumi-Nakaseko H; Takei Y; Sugiyama A
    J Pharmacol Sci; 2024 Oct; 156(2):134-141. PubMed ID: 39179332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological β-adrenoceptor blockade can augment torsadogenic action of I
    Goto A; Hagiwara-Nagasawa M; Chiba K; Kambayashi R; Nunoi Y; Izumi-Nakaseko H; Matsumoto A; Kanda Y; Sugiyama A
    J Pharmacol Sci; 2019 Sep; 141(1):86-89. PubMed ID: 31636019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone alone did not induce torsade de pointes: Experimental evidence from the chronic atrioventricular block model dogs.
    Nunoi Y; Chiba K; Hagiwara-Nagasawa M; Goto A; Kambayashi R; Izumi-Nakaseko H; Takei Y; Matsumoto A; Watanabe Y; Sugiyama A
    J Pharmacol Sci; 2020 Aug; 143(4):330-332. PubMed ID: 32499094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cardiac α
    Kawakami S; Kambayashi R; Takada K; Aimoto M; Nagasawa Y; Takahara A
    J Pharmacol Sci; 2022 Oct; 150(2):67-73. PubMed ID: 36055753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of J-T
    Goto A; Hagiwara-Nagasawa M; Kambayashi R; Chiba K; Izumi-Nakaseko H; Naito AT; Kanda Y; Sugiyama A
    Cardiovasc Toxicol; 2019 Aug; 19(4):357-364. PubMed ID: 30712162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Safety Margin of an Antipsychotic Drug Haloperidol for Torsade de Pointes Using the Chronic Atrioventricular Block Dogs.
    Izumi-Nakaseko H; Nakamura Y; Cao X; Wada T; Ando K; Sugiyama A
    Cardiovasc Toxicol; 2017 Jul; 17(3):319-325. PubMed ID: 27738880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone, QTc interval prolongation, and torsade de pointes: a systematic review of case reports.
    Vieweg WV; Hasnain M; Hancox JC; Baranchuk A; Digby GC; Kogut C; Crouse EL; Koneru JN; Deshmukh A; Pandurangi AK
    Psychopharmacology (Berl); 2013 Aug; 228(4):515-24. PubMed ID: 23812796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased short-term variability of repolarization predicts d-sotalol-induced torsades de pointes in dogs.
    Thomsen MB; Verduyn SC; Stengl M; Beekman JD; de Pater G; van Opstal J; Volders PG; Vos MA
    Circulation; 2004 Oct; 110(16):2453-9. PubMed ID: 15477402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo analysis of torsadogenic potential of an antipsychotic drug paliperidone using the acute atrioventricular block rabbit as a proarrhythmia model.
    Hagiwara M; Kambayashi R; Aimoto M; Nagasawa Y; Takahara A
    J Pharmacol Sci; 2016 Sep; 132(1):48-54. PubMed ID: 27262905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high frequency relationship: implications for torsadogenic hERG blockers.
    Champeroux P; Le Guennec JY; Jude S; Laigot C; Maurin A; Sola ML; Fowler JS; Richard S; Thireau J
    Br J Pharmacol; 2016 Feb; 173(3):601-12. PubMed ID: 26589499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
    Vos MA; Verduyn SC; Gorgels AP; Lipcsei GC; Wellens HJ
    Circulation; 1995 Feb; 91(3):864-72. PubMed ID: 7828315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the late sodium current by ATX-II and ranolazine affects the reverse use-dependence and proarrhythmic liability of IKr blockade.
    Jia S; Lian J; Guo D; Xue X; Patel C; Yang L; Yuan Z; Ma A; Yan GX
    Br J Pharmacol; 2011 Sep; 164(2):308-16. PubMed ID: 21182492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of haemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
    Champéroux P; Fares R; Bastogne T; Richard S; Le Guennec JY; Thireau J
    Br J Pharmacol; 2022 Sep; 179(18):4549-4562. PubMed ID: 35751378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced long QT syndrome: Concept and non-clinical models for predicting the onset of drug-induced torsade de pointes in patients in compliance with ICH E14/S7B guidance.
    Sugiyama A; Goto A; Izumi-Nakaseko H; Takei Y; Takahara A; Kambayashi R
    J Pharmacol Exp Ther; 2024 Aug; ():. PubMed ID: 39168651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive and reliable proarrhythmia in vivo animal models for predicting drug-induced torsades de pointes in patients with remodelled hearts.
    Sugiyama A
    Br J Pharmacol; 2008 Aug; 154(7):1528-37. PubMed ID: 18552873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.